133 related articles for article (PubMed ID: 11161960)
1. Does the GH-IGF axis play a role in cancer pathogenesis?
Cohen P; Clemmons DR; Rosenfeld RG
Growth Horm IGF Res; 2000 Dec; 10(6):297-305. PubMed ID: 11161960
[TBL] [Abstract][Full Text] [Related]
2. Growth hormone and prostate cancer: guilty by association?
Grimberg A; Cohen P
J Endocrinol Invest; 1999; 22(5 Suppl):64-73. PubMed ID: 10442574
[TBL] [Abstract][Full Text] [Related]
3. Cancer in growth hormone excess and growth hormone deficit.
Guevara-Aguirre J; Peña G; Acosta W; Pazmiño G; Saavedra J; Soto L; Lescano D; Guevara A; Gavilanes AWD
Endocr Relat Cancer; 2023 Oct; 30(10):. PubMed ID: 37428642
[TBL] [Abstract][Full Text] [Related]
4. GH-dependent growth of experimentally induced carcinomas in vivo.
Marker PC; Unterberger CJ; Swanson SM
Endocr Relat Cancer; 2023 May; 30(5):. PubMed ID: 36826838
[TBL] [Abstract][Full Text] [Related]
5. The science behind the relations among cancer, height, growth patterns, and growth hormone axis.
Boguszewski CL; Boguszewski MCDS; de Herder WW
Endocr Relat Cancer; 2023 Apr; 30(4):. PubMed ID: 36779772
[TBL] [Abstract][Full Text] [Related]
6. Acromegaly and Cancer: An Update.
Danilowicz K; Sosa S
Arch Med Res; 2023 Dec; 54(8):102914. PubMed ID: 38007382
[TBL] [Abstract][Full Text] [Related]
7. The role of IGFBP-3 in tumor development and progression: enlightenment for diagnosis and treatment.
Wang Y; Zhang H; Zhang X; Mu P; Zhao L; Qi R; Zhang Y; Zhu X; Dong Y
Med Oncol; 2024 May; 41(6):141. PubMed ID: 38714554
[TBL] [Abstract][Full Text] [Related]
8. Prevention of Cancer Through Lifestyle Changes.
Barnard RJ
Evid Based Complement Alternat Med; 2004 Dec; 1(3):233-239. PubMed ID: 15841256
[TBL] [Abstract][Full Text] [Related]
9. Does growth hormone cause cancer?
Jenkins PJ; Mukherjee A; Shalet SM
Clin Endocrinol (Oxf); 2006 Feb; 64(2):115-21. PubMed ID: 16430706
[TBL] [Abstract][Full Text] [Related]
10. [Physiology of the GH-IGF axis].
Martinelli CE; Custódio RJ; Aguiar-Oliveira MH
Arq Bras Endocrinol Metabol; 2008 Jul; 52(5):717-25. PubMed ID: 18797577
[TBL] [Abstract][Full Text] [Related]
11. Growth hormone treatment and risk of malignancy.
Chae HW; Kim DH; Kim HS
Korean J Pediatr; 2015 Feb; 58(2):41-6. PubMed ID: 25774194
[TBL] [Abstract][Full Text] [Related]
12. Growth Hormone's Links to Cancer.
Boguszewski CL; Boguszewski MCDS
Endocr Rev; 2019 Apr; 40(2):558-574. PubMed ID: 30500870
[TBL] [Abstract][Full Text] [Related]
13. Covert actions of growth hormone: fibrosis, cardiovascular diseases and cancer.
Kopchick JJ; Basu R; Berryman DE; Jorgensen JOL; Johannsson G; Puri V
Nat Rev Endocrinol; 2022 Sep; 18(9):558-573. PubMed ID: 35750929
[TBL] [Abstract][Full Text] [Related]
14. Short and Long-Term Effects of Growth Hormone in Children and Adolescents With GH Deficiency.
Ranke MB
Front Endocrinol (Lausanne); 2021; 12():720419. PubMed ID: 34539573
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological inhibition of tumor anabolism and host catabolism as a cancer therapy.
Schcolnik-Cabrera A; Chavez-Blanco A; Dominguez-Gomez G; Juarez M; Vargas-Castillo A; Ponce-Toledo RI; Lai D; Hua S; Tovar AR; Torres N; Perez-Montiel D; Diaz-Chavez J; Duenas-Gonzalez A
Sci Rep; 2021 Mar; 11(1):5222. PubMed ID: 33664364
[TBL] [Abstract][Full Text] [Related]
16. The combination of orlistat, lonidamine and 6-diazo-5-oxo-L-norleucine induces a quiescent energetic phenotype and limits substrate flexibility in colon cancer cells.
Schcolnik-Cabrera A; Chavez-Blanco A; Dominguez-Gomez G; Juarez M; Lai D; Hua S; Tovar AR; Diaz-Chavez J; Duenas-Gonzalez A
Oncol Lett; 2020 Sep; 20(3):3053-3060. PubMed ID: 32782623
[TBL] [Abstract][Full Text] [Related]
17. Insulin-Like Growth Factor 2 (IGF2) Signaling in Colorectal Cancer-From Basic Research to Potential Clinical Applications.
Kasprzak A; Adamek A
Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31623387
[TBL] [Abstract][Full Text] [Related]
18. Predictors of colonic pathologies in active acromegaly: single tertiary center experience.
Iliaz R; Dogansen SC; Tanrikulu S; Yalin GY; Cavus B; Gulluoglu M; Akyuz F; Yarman S
Wien Klin Wochenschr; 2018 Sep; 130(17-18):511-516. PubMed ID: 30062505
[TBL] [Abstract][Full Text] [Related]
19. Capromorelin: a ghrelin receptor agonist and novel therapy for stimulation of appetite in dogs.
Rhodes L; Zollers B; Wofford JA; Heinen E
Vet Med Sci; 2018 Feb; 4(1):3-16. PubMed ID: 29468076
[TBL] [Abstract][Full Text] [Related]
20. Physiologic Growth Hormone-Replacement Therapy and Craniopharyngioma Recurrence in Pediatric Patients: A Meta-Analysis.
Alotaibi NM; Noormohamed N; Cote DJ; Alharthi S; Doucette J; Zaidi HA; Mekary RA; Smith TR
World Neurosurg; 2018 Jan; 109():487-496.e1. PubMed ID: 28987837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
